John T. Poirier, Ph.D.
Affiliations: | 2012 | Cellular and Molecular Medicine | Johns Hopkins University, Baltimore, MD |
Area:
Oncology, Virology BiologyGoogle:
"John Poirier"Parents
Sign in to add mentor| Diane E. Griffin | grad student | 2012 | Johns Hopkins | |
| (Preclinical and clinical studies of Seneca Valley Virus, a therapeutically promising oncolytic picornavirus with neuroendocrine tropism.) | ||||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Tendler S, Dunphy MP, Agee M, et al. (2024) First-in-human imaging with [Zr]Zr-DFO-SC16.56 anti-DLL3 antibody in patients with high-grade neuroendocrine tumors of the lung and prostate. Medrxiv : the Preprint Server For Health Sciences |
| Zavitsanou AM, Pillai R, Hao Y, et al. (2023) KEAP1 mutation in lung adenocarcinoma promotes immune evasion and immunotherapy resistance. Cell Reports. 42: 113295 |
| Pillai R, LeBoeuf SE, Hao Y, et al. (2023) Glutamine antagonist DRP-104 suppresses tumor growth and enhances response to checkpoint blockade in mutant lung cancer. Biorxiv : the Preprint Server For Biology |
| Rudin CM, Balli D, Lai WV, et al. (2023) Clinical benefit from immunotherapy in patients with small cell lung cancer is associated with tumor capacity for antigen presentation. Journal of Thoracic Oncology : Official Publication of the International Association For the Study of Lung Cancer |
| Deng J, Peng DH, Fenyo D, et al. (2023) metabolomics identifies CD38 as an emergent vulnerability in -mutant lung cancer. Biorxiv : the Preprint Server For Biology |
| Pan Y, Han H, Hu H, et al. (2022) KMT2D deficiency drives lung squamous cell carcinoma and hypersensitivity to RTK-RAS inhibition. Cancer Cell |
| Chemi F, Pearce SP, Clipson A, et al. (2022) cfDNA methylome profiling for detection and subtyping of small cell lung cancers. Nature Cancer |
| Caeser R, Egger JV, Chavan S, et al. (2022) Genomic and transcriptomic analysis of a library of small cell lung cancer patient-derived xenografts. Nature Communications. 13: 2144 |
| Tully KM, Tendler S, Carter LM, et al. (2022) Radioimmunotherapy Targeting Delta-like Ligand 3 in Small Cell Lung Cancer exhibits antitumor efficacy with low toxicity. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research |
| Quintanal-Villalonga A, Taniguchi H, Hao Y, et al. (2021) Inhibition of XPO1 sensitizes small cell lung cancer to first- and second-line chemotherapy. Cancer Research |